Meredith C Foster1, Lesley A Inker1, Chi-Yuan Hsu2, John H Eckfeldt3, Andrew S Levey1, Meda E Pavkov4, Bryan D Myers5, Peter H Bennett6, Paul L Kimmel7, Ramachandran S Vasan8, Josef Coresh9, Robert G Nelson10. 1. Tufts Medical Center, Boston, MA. 2. University of California, San Francisco, San Francisco, CA. 3. University of Minnesota, Minneapolis, MN. 4. Centers for Disease Control and Prevention, Atlanta, GA. 5. Stanford University, Stanford, CA. 6. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ. 7. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. 8. Boston University, Boston, MA. 9. Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 10. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ. Electronic address: rnelson@nih.gov.
Abstract
BACKGROUND: A growing number of serum filtration markers are associated with mortality and end-stage renal disease (ESRD) in adults. Whether β-trace protein (BTP) and β2-microglobulin (B2M) are associated with these outcomes in adults with type 2 diabetes is not known. STUDY DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: 250 Pima Indians with type 2 diabetes (69% women; mean age, 42 years; mean diabetes duration, 11 years). PREDICTORS: Serum BTP, B2M, and glomerular filtration rate measured by iothalamate clearance (mGFR) or estimated using creatinine (eGFRcr) or cystatin C level (eGFRcys). OUTCOMES & MEASUREMENTS: Incident ESRD and all-cause mortality through December 2013. HRs were reported per interquartile range decrease of the inverse of BTP and B2M (1/BTP and 1/B2M) using Cox regression. Improvement in risk prediction with the addition of BTP or B2M level to established markers (eGFRcys with mGFR or eGFRcr) was evaluated using C statistics, continuous net reclassification improvement, and relative integrated discrimination improvement (RIDI). RESULTS: During a median follow-up of 14 years, 69 participants developed ESRD and 95 died. Both novel markers were associated with ESRD in multivariable models. BTP level remained statistically significant after further adjustment for mGFR (1/BTP, 1.53 [95% CI, 1.01-2.30]; 1/B2M, 1.54 [95% CI, 0.98-2.42]). B2M level was associated with mortality in multivariable models and after further adjustment for mGFR (HR, 2.12; 95% CI, 1.38-3.26). The addition of B2M level to established markers increased the C statistic for mortality but only weakly when assessed by either continuous net reclassification improvement or RIDI; none was improved for ESRD by the addition of these markers. LIMITATIONS: Small sample size, single measurements of markers. CONCLUSIONS: In Pima Indians with type 2 diabetes, BTP and, to a lesser extent, B2M levels were associated with ESRD. B2M level was associated with mortality after adjustment for traditional risk factors and established filtration markers. Further studies are warranted to confirm whether inclusion of B2M level in a multimarker approach leads to improved risk prediction for mortality in this population. Published by Elsevier Inc.
BACKGROUND: A growing number of serum filtration markers are associated with mortality and end-stage renal disease (ESRD) in adults. Whether β-trace protein (BTP) and β2-microglobulin (B2M) are associated with these outcomes in adults with type 2 diabetes is not known. STUDY DESIGN: Longitudinal cohort study. SETTING & PARTICIPANTS: 250 Pima Indians with type 2 diabetes (69% women; mean age, 42 years; mean diabetes duration, 11 years). PREDICTORS: Serum BTP, B2M, and glomerular filtration rate measured by iothalamate clearance (mGFR) or estimated using creatinine (eGFRcr) or cystatin C level (eGFRcys). OUTCOMES & MEASUREMENTS: Incident ESRD and all-cause mortality through December 2013. HRs were reported per interquartile range decrease of the inverse of BTP and B2M (1/BTP and 1/B2M) using Cox regression. Improvement in risk prediction with the addition of BTP or B2M level to established markers (eGFRcys with mGFR or eGFRcr) was evaluated using C statistics, continuous net reclassification improvement, and relative integrated discrimination improvement (RIDI). RESULTS: During a median follow-up of 14 years, 69 participants developed ESRD and 95 died. Both novel markers were associated with ESRD in multivariable models. BTP level remained statistically significant after further adjustment for mGFR (1/BTP, 1.53 [95% CI, 1.01-2.30]; 1/B2M, 1.54 [95% CI, 0.98-2.42]). B2M level was associated with mortality in multivariable models and after further adjustment for mGFR (HR, 2.12; 95% CI, 1.38-3.26). The addition of B2M level to established markers increased the C statistic for mortality but only weakly when assessed by either continuous net reclassification improvement or RIDI; none was improved for ESRD by the addition of these markers. LIMITATIONS: Small sample size, single measurements of markers. CONCLUSIONS: In Pima Indians with type 2 diabetes, BTP and, to a lesser extent, B2M levels were associated with ESRD. B2M level was associated with mortality after adjustment for traditional risk factors and established filtration markers. Further studies are warranted to confirm whether inclusion of B2M level in a multimarker approach leads to improved risk prediction for mortality in this population. Published by Elsevier Inc.
Authors: Nrupen A Bhavsar; Lawrence J Appel; John W Kusek; Gabriel Contreras; George Bakris; Josef Coresh; Brad C Astor Journal: Am J Kidney Dis Date: 2011-09-22 Impact factor: 8.860
Authors: R G Nelson; P H Bennett; G J Beck; M Tan; W C Knowler; W E Mitch; G H Hirschman; B D Myers Journal: N Engl J Med Date: 1996-11-28 Impact factor: 91.245
Authors: Abeba M Berhane; E Jennifer Weil; William C Knowler; Robert G Nelson; Robert L Hanson Journal: Clin J Am Soc Nephrol Date: 2011-08-18 Impact factor: 8.237
Authors: Nikhil C Munshi; Kenneth C Anderson; P Leif Bergsagel; John Shaughnessy; Antonio Palumbo; Brian Durie; Rafael Fonseca; A Keith Stewart; Jean-Luc Harousseau; Meletios Dimopoulos; Sundar Jagannath; Roman Hajek; Orhan Sezer; Robert Kyle; Pieter Sonneveld; Michele Cavo; S Vincent Rajkumar; Jesus San Miguel; John Crowley; Hervé Avet-Loiseau Journal: Blood Date: 2011-02-03 Impact factor: 22.113
Authors: B Vasquez; E V Flock; P J Savage; M Nagulesparan; L J Bennion; H R Baird; P H Bennett Journal: Diabetologia Date: 1984-02 Impact factor: 10.122
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Lesley A Inker; Josef Coresh; Yingying Sang; Chi-Yuan Hsu; Meredith C Foster; John H Eckfeldt; Amy B Karger; Robert G Nelson; Xun Liu; Mark Sarnak; Lawrence J Appel; Morgan Grams; Dawei Xie; Paul L Kimmel; Harold Feldman; Vasan Ramachandran; Andrew S Levey Journal: Clin J Am Soc Nephrol Date: 2016-11-10 Impact factor: 8.237
Authors: M C Foster; D E Weiner; A G Bostom; M A Carpenter; L A Inker; P Jarolim; A A Joseph; J W Kusek; T Pesavento; M A Pfeffer; M Rao; S D Solomon; A S Levey Journal: Am J Transplant Date: 2017-03-30 Impact factor: 8.086
Authors: Xun Liu; Meredith C Foster; Hocine Tighiouart; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Josef Coresh; John H Eckfeldt; Harold I Feldman; Tom Greene; L Lee Hamm; Jiang He; Edward Horwitz; Julia Lewis; Ana C Ricardo; Haochang Shou; Raymond R Townsend; Matthew R Weir; Lesley A Inker; Andrew S Levey Journal: Am J Kidney Dis Date: 2016-09-20 Impact factor: 8.860
Authors: Lesley A Inker; Hocine Tighiouart; Josef Coresh; Meredith C Foster; Amanda H Anderson; Gerald J Beck; Gabriel Contreras; Tom Greene; Amy B Karger; John W Kusek; James Lash; Julia Lewis; Jeffrey R Schelling; Sankar D Navaneethan; James Sondheimer; Tariq Shafi; Andrew S Levey Journal: Am J Kidney Dis Date: 2015-09-09 Impact factor: 8.860
Authors: Meredith C Foster; Josef Coresh; Chi-Yuan Hsu; Dawei Xie; Andrew S Levey; Robert G Nelson; John H Eckfeldt; Ramachandran S Vasan; Paul L Kimmel; Jeffrey Schelling; Michael Simonson; James H Sondheimer; Amanda Hyre Anderson; Sanjeev Akkina; Harold I Feldman; John W Kusek; Akinlolu O Ojo; Lesley A Inker Journal: Am J Kidney Dis Date: 2016-03-03 Impact factor: 8.860
Authors: Lesley A Inker; Sara J Couture; Hocine Tighiouart; Alison G Abraham; Gerald J Beck; Harold I Feldman; Tom Greene; Vilmundur Gudnason; Amy B Karger; John H Eckfeldt; Bertram L Kasiske; Michael Mauer; Gerjan Navis; Emilio D Poggio; Peter Rossing; Michael G Shlipak; Andrew S Levey Journal: Am J Kidney Dis Date: 2020-12-07 Impact factor: 8.860